Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Brinton, US
Chris Brinton, Leesburg, VA US
| Patent application number | Description | Published |
|---|---|---|
| 20100100257 | Visual airport surface and terminal area data system - The invention supports the study of operations and provides a large data store of surface and terminal area operations, as well as means of analyzing and understanding that data. It fuses multiple surveillance and flight data sources to provide analysis functionality for both airborne and surface based flights. This provides a wider range of data to make intelligent categorization and derived data analysis decisions. The invention implements custom logic for matching flights to corresponding data messages by maintaining its own key mappings between data tables during import so that keys are unique to an installation and do not require sequences. This provides the ability to export datasets through the PostgreSQL dump utility and then import it into an existing database (using the PostgreSQL restore utility) without creating overlapping, duplicate or conflicting keys. XML based format is used and import and export features is that allow users to share these custom queries. | 04-22-2010 |
James Eric Brinton, Greenwood, SC US
| Patent application number | Description | Published |
|---|---|---|
| 20080207108 | Roof Light System Having a Ventilation Device with Improved Flexibility - The roof light system is composed by a roof unit ( | 08-28-2008 |
| 20100011682 | SEAMLESS DECK-SEALING SURROUND FOR SKYLIGHTS AND ROOF WINDOWS - A seamless surround for a rectangular skylight assembly is provided. Each side of the rectangular surround is characterized as having an obtuse-angled profile having an angle of between greater than 90 degrees and about 100 degrees, the profile including a vertically extending surface and a downwardly sloping surface. The vertically extending surfaces abut curb members attached to the skylight assembly and include apertures therethrough for receipt of a joining element. The downwardly sloping surfaces abut a building rooftop and further include apertures therethrough for receipt of a joining element. The roof-abutting side of the downwardly sloping surfaces includes a barrier material attached thereto. The barrier material may be any suitable air and water barrier, such as a polyurethane foam or a thermoplastic elastomer. A method of installing a skylight having the seamless surround is also provided. | 01-21-2010 |
| 20100018138 | VENTILATED CURB-MOUNT SKYLIGHT WITH SEPARABLE HINGE - Provided herein is a curb-mounted skylight having a rigid plastic curb frame, a mechanism for firmly securing the curb frame to an opening in a building, a transparent or translucent covering element, and a mechanism for retaining the covering element on the frame. The curb frame includes a fixed base frame (having an interior frame and a counter-flashing element) and a moveable sash frame (having an accessory shelf and a sash). The base frame and the sash frame may be connected to one another by a first hinge member integral with the counter-flashing element and a cooperative and complementary-shaped second hinge member attached to the sash. The hinge members form a watertight seal and may be disengaged to permit the sash to be removed from the skylight assembly during installation, if so desired. Because the frame and hinge components are made of plastic, the skylight assembly is relatively lightweight. | 01-28-2010 |
Margo A. Brinton, Decatur, GA US
| Patent application number | Description | Published |
|---|---|---|
| 20090186842 | Methods and compositions for inhibition of viral replication - The present invention is directed to methods and compositions that are effective in the inhibition of viral replication. In particular, the methods and compositions are effective at interfering with the activity of host cell proteins required in viral replication. For example, an embodiment of the invention is directed to methods and compositions comprising RNA sequences to which the host cell proteins TIAR and/or TIA-1 bind. | 07-23-2009 |
| 20100166704 | Methods and compositions for inhibition of viral replication - The present invention is directed to methods and compositions that are effective in the inhibition of viral replication. In particular, the methods and compositions are effective at interfering with the activity of host cell proteins required in viral replication. For example, an embodiment of the invention is directed to inhibition of flavivirus replication wherein the replication is affected by changing the normal interactions of the host cell protein TIAR or TIA-1. | 07-01-2010 |
Marshall K. Brinton, Spicer, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20080279863 | THERAPEUTIC ANTIBODIES FOR TREATMENT AND PROPHYLAXIS OF TRANSMITTABLE VIRAL DISEASES - The invention provides methods and compositions for the treatment and prevention of a transmittable disease in a subject, such as avians and mammals. The methods and compositions of the invention specifically make use of avian antibodies to the disease to be treated or prevented. Administration of such avian antibodies to a subject has been shown effective for reducing mortality in a population of subjects that are infected, or become infected, with the disease. The invention also provides kits useful for detecting the presence of transmittable diseases in subjects. | 11-13-2008 |
| 20110150904 | Therapeutic Antibodies for Treatment and Prophylaxis of Transmittable Viral Diseases - The invention provides methods and compositions for the treatment and prevention of a transmittable disease in a subject, such as avians and mammals. The methods and compositions of the invention specifically make use of avian antibodies to the disease to be treated or prevented. Administration of such avian antibodies to a subject has been shown effective for reducing mortality in a population of subjects that are infected, or become infected, with the disease. The invention also provides kits useful for detecting the presence of transmittable diseases in subjects. | 06-23-2011 |
Michael D. Brinton, White Plains, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090307579 | VIEWING FILE MODIFICATIONS - Upon closing and/or saving a file, a user may view changes made to the file. | 12-10-2009 |
Michael D. Brinton, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090189791 | FONT OR KEYSTROKE BIOMETRICS - Systems are provided that include an input device with a plurality of keys, at least one of the plurality of keys including a biometric sensor disposed therein. The system generally executes an application, receives input from a plurality of users using the input device, determines the identity of the user submitting the input, and attributes actual contribution in the application to the identified user. | 07-30-2009 |
Roberta Diaz Brinton, Rancho Palos Verdes, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080200441 | ESTROGEN RECEPTOR MODULATORS ASSOCIATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE - Selective estrogen receptor modulators, as well their related pharmaceutical compositions and methods of use, are provided herein. These estrogen receptor modulators include compounds that primarily exhibit estrogen receptor antagonist activity or primarily exhibit selective estrogen receptor antagonist and agonist activity, i.e., SERM activity, in specific tissue types. Particular embodiments provide compounds that behave as NeuroSERMs promoting neurotrophism and neuroprotection in brain tissue. These NeuroSERMs represent a subset of the modulators compounds provided herein that can cross the blood-brain-barrier and exert estrogen receptor agonist-like effects in the brain. The compounds should be useful for treating a variety of diseases, particularly estrogen receptor-mediated diseases and disorders, such as osteoporosis, breast and endometrial cancers, atherosclerosis and Alzheimer's disease. | 08-21-2008 |
| 20100105646 | ALLOPREGNANOLONE IN A METHOD FOR ENHANCING NEUROLOGICAL FUNCTION (ALZHEIMER DISEASE) - Neuro-enhancing agents, compositions and methods are disclosed herein. Preferred neuro-enhancing agents of the present invention include progesterone and metabolites of progesterone, such as 3α-hydroxy-5α-pregnan-20-one (THP). These agents yield neuro-enhancing effects on neural cells that include neural progenitor and/or stem cells, whereby the agents stimulate mitosis of neural progenitor cells, stimulate neurite growth and organization, protect against neural loss, or one or more of these neural processes. Thus, the neuro-enhancing agents, compositions and methods disclosed herein are useful to reverse or prevent neurological disease or defects associated with neural loss or degeneration, such as Alzheimer's disease, neurological injuries, including injuries resulting from radiation therapy, and age-related neurological decline, including impairments in memory and learning. | 04-29-2010 |
| 20100113586 | PHYTOESTROGENIC FORMULATIONS FOR ALLEVIATION OR PREVENTION OF MENOPAUSAL SYMPTOMS - Select phytoestrogen pharmaceutical compositions and methods of use for preventing or reducing one or more symptoms associated with pre menopause, menopause, and/or post menopause are described herein. These select phytoestrogen formulations are composed only of two or more plant-derived estrogenic molecules and/or their structural analogues and exhibit binding preference to ERβ over ERα and agonist activity in the brain. These ERβ-selective phytoestrogen formulations cross the blood-brain-barrier and promote estrogen-associated neurotrophism and neuroprotection mechanisms in the brain, without activating proliferative mechanisms in the reproductive tissues and are therefore devoid of other estrogen-associated problematic aspects. The formulations can be administered enterally, transdermally, transmucosally, intranasally or parenterally. The formulations preferably contain combinations of compounds, and can be formulated for daily, sustained, delayed or weekly/monthly administration. In a preferred embodiment, these are administered to women who are in menopause or post menopausal, most preferably early in menopausal. | 05-06-2010 |
| 20100204192 | AGENTS, COMPOSITIONS AND METHODS FOR ENHANCING NEUROLOGICAL FUNCTION - Neuro-enhancing agents, compositions and methods are disclosed herein. Preferred neuro-enhancing agents of the present invention include progesterone and metabolites of progesterone, such as 3α-hydroxy-5α-pregnan-20-one (THP). These agents yield neuro-enhancing effects on neural cells that include neural progenitor and/or stem cells, whereby the agents stimulate mitosis of neural progenitor cells, stimulate neurite growth and organization, protect against neural loss, or one or more of these neural processes. Thus, the neuro-enhancing agents, compositions and methods disclosed herein are useful to reverse or prevent neurological disease or defects associated with neural loss or degeneration, such as Alzheimer's disease, neurological injuries, including injuries resulting from radiation therapy, and age-related neurological decline, including impairments in memory and learning. | 08-12-2010 |
| 20110091435 | PHYTOESTROGENIC FORMULATIONS FOR ALLEVIATION OR PREVENTION OF HAIR LOSS - Select phytoestrogen pharmaceutical compositions and methods of use for preventing or reducing one or more symptoms associated with hair loss or prostate cancer/prostate hypertrophy are described herein. These select phytoestrogen formulations are preferably composed only of two or more plant-derived estrogenic molecules and/or their structural analogues and exhibit binding preference to ERβ over ERα and agonist activity in non-reproductive tissues including brain. | 04-21-2011 |
Todd Jeffrey Brinton, Menlo Park, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100112081 | USE OF PLATELET RICH PLASMA COMPOSITION IN THE TREATMENT OF CARDIAC CONDUCTION ABNORMALITIES - Methods and kits for treating a cardiac arrhythmia using a platelet rich plasma (PRP) composition are provided. Any type of arrhythmia may be treated using the PRP composition. The PRP composition may comprise PRP developed using blood collected from a patient suffering the cardiac arrhythmia. The PRP composition may be buffered to a physiological pH and may include one or more anti-arrhythmic agents, anti-coagulants, or other drugs. The PRP composition may be delivered using a nebulizer, minimally invasively, or surgically. In some embodiments, the PRP composition may be coated on one or more medical devices. The PRP composition may be delivered to an identified portion of the electrical conduction system of the heart affected and/or causing the arrhythmia to occur. | 05-06-2010 |